Read + Share
Amedeo Smart
Independent Medical Education
Jain SU, Khazaei S, Marchione DM, Lundgren SM, et al. Histone H3.3 G34 mutations promote aberrant PRC2 activity and drive tumor progression. Proc Natl Acad Sci U S A 2020;117:27354-27364.PMID: 33067396
Email
LinkedIn
Facebook
Twitter
Privacy Policy